Targets of polyamine dysregulation in major depression and suicide: Activity-dependent feedback, excitability, and neurotransmission

Neuroscience and Biobehavioral Reviews

Volumn 66, Issue , 2016, Pages 80-91

  Limon, Agenor ^a   Mamdani, Firoza ^a   Hjelm, Brooke E ^a   Vawter, Marquis P ^a   Sequeira, Adolfo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Excitability; Homeostasis; Ion channels; Major depression; Neurotransmitter receptors; Polyamine system; Suicide

Indexed keywords

AGMATINE; AMPA RECEPTOR; BUNGAROTOXIN RECEPTOR; CALCIUM ACTIVATED POTASSIUM CHANNEL; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 3; GLUTAMATE RECEPTOR 4; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR1.2; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.3; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR3.1; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR3.4; KAINIC ACID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4BETA2; PHOSPHATIDYLINOSITOL 3 KINASE; POTASSIUM CHANNEL; PUTRESCINE; SODIUM CHANNEL; SPERMIDINE; SPERMINE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M4; TRANSIENT RECEPTOR POTENTIAL CHANNEL M5; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLOID RECEPTOR 1; POLYAMINE;

ACTION POTENTIAL; ALLOSTERISM; BINDING AFFINITY; BOLD SIGNAL; BRAIN FUNCTION; BRAIN REGION; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; DOWN REGULATION; ELECTROENCEPHALOGRAM; ENZYME ACTIVITY; FEEDBACK SYSTEM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE EXPRESSION; HOMEOSTASIS; HUMAN; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MAJOR DEPRESSION; NERVE EXCITABILITY; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; SUICIDE; SYNAPTIC TRANSMISSION; BRAIN;

BRAIN; DEPRESSIVE DISORDER, MAJOR; HUMANS; POLYAMINES; SUICIDE; SYNAPTIC TRANSMISSION;

EID: 84966709480     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.04.010     Document Type: Review

References (175)

1. Ahern G.P., Wang X., Miyares R.L. Polyamines are potent ligands for the capsaicin receptor TRPV1. J. Biol. Chem. 2006, 281:8991-8995.
2. Ahrens B., Muller-Oerlinghausen B. Does lithium exert an independent antisuicidal effect?. Pharmacopsychiatry 2001, 34:132-136.
3. Aizenman C.D., Munoz-Elias G., Cline H.T. Visually driven modulation of glutamatergic synaptic transmission is mediated by the regulation of intracellular polyamines. Neuron 2002, 34:623-634.
4. Alcaro A., Panksepp J., Witczak J., Hayes D.J., Northoff G. Is subcortical-cortical midline activity in depression mediated by glutamate and GABA? A cross-species translational approach. Neurosci. Biobehav. Rev. 2010, 34:592-605.
5. Aragam N., Wang K.S., Anderson J.L., Liu X. TMPRSS9 and GRIN2B are associated with neuroticism: a genome-wide association study in a European sample. J. Mol. Neurosci. 2013, 50:250-256.
6. Aston C., Jiang L., Sokolov B.P. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol. Psychiatry 2005, 10:309-322.
7. Babini E., Paukert M., Geisler H.S., Grunder S. Alternative splicing and interaction with di- and polyvalent cations control the dynamic range of acid-sensing ion channel 1 (ASIC1). J. Biol. Chem. 2002, 277:41597-41603.
8. Banks S.J., Eddy K.T., Angstadt M., Nathan P.J., Phan K.L. Amygdala-frontal connectivity during emotion regulation. Soc. Cogn. Affect Neurosci. 2007, 2:303-312.
9. Baudry M., Lynch G., Gall C. Induction of ornithine decarboxylase as a possible mediator of seizure-elicited changes in genomic expression in rat hippocampus. J. Neurosci. 1986, 6:3430-3435.
10. Bauer E.P., Schafe G.E., LeDoux J.E. NMDA receptors and L-type voltage-gated calcium channels contribute to long-term potentiation and different components of fear memory formation in the lateral amygdala. J. Neurosci. 2002, 22:5239-5249.
11. Bhat S., Dao D.T., Terrillion C.E., Arad M., Smith R.J., Soldatov N.M., Gould T.D. CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease. Prog. Neurobiol. 2012, 99:1-14.
12. Bocchetta A., Ardau R., Burrai C., Chillotti C., Quesada G., Del Zompo M. Suicidal behavior on and off lithium prophylaxis in a group of patients with prior suicide attempts. J. Clin. Psychopharmacol. 1998, 18:384-389.
13. Bondy S.C., Mitchell C.L., Rahmaan S., Mason G. Regional variation in the response of cerebral ornithine decarboxylase to electroconvulsive shock. Neurochem. Pathol. 1987, 7:129-141.
14. Brown T.E., Chirila A.M., Schrank B.R., Kauer J.A. Loss of interneuron LTD and attenuated pyramidal cell LTP in Trpv1 and Trpv3 KO mice. Hippocampus 2013, 23:662-671.
15. Casamassima F., Huang J., Fava M., Sachs G.S., Smoller J.W., Cassano G.B., Lattanzi L., Fagerness J., Stange J.P., Perlis R.H. Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B:303-309.
16. Cavanaugh D.J., Chesler A.T., Jackson A.C., Sigal Y.M., Yamanaka H., Grant R., O'Donnell D., Nicoll R.A., Shah N.M., Julius D., Basbaum A.I. Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J. Neurosci. 2011, 31:5067-5077.
17. Chan H.F., Chen M.L., Su J.J., Ko L.C., Lin C.H., Wu R.M. A novel neuropsychiatric phenotype of KCNJ2 mutation in one Taiwanese family with Andersen-Tawil syndrome. J. Hum. Genet. 2010, 55:186-188.
18. Chang B.K. Inhibitory effects of a calcium antagonist on ornithine decarboxylase induction in pancreatic cancer cell lines. Pancreas 1991, 6:631-636.
19. Charnet P., Labarca C., Cohen B.N., Davidson N., Lester H.A., Pilar G. Pharmacological and kinetic properties of alpha 4 beta 2 neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J. Physiol. 1992, 450:375-394.
20. Chavez A.E., Chiu C.Q., Castillo P.E. TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. Nat. Neurosci. 2010, 13:1511-1518.
21. + channel TREK-1. EMBO J. 2005, 24:44-53.
22. Chen W., Harnett M.T., Smith S.M. Modulation of neuronal voltage-activated calcium and sodium channels by polyamines and pH. Channels (Austin) 2007, 1:281-290.
23. Chen G.G., Fiori L.M., Moquin L., Gratton A., Mamer O., Mechawar N., Turecki G. Evidence of altered polyamine concentrations in cerebral cortex of suicide completers. Neuropsychopharmacology 2010, 35:1477-1484.
24. Cino I., Formenti A. Spermine biphasically affects N-type calcium channel currents in adult dorsal root ganglion neurons of the rat. Biochim. Biophys. Acta 2008, 1778:2437-2443.
25. Comte M., Schon D., Coull J.T., Reynaud E., Khalfa S., Belzeaux R., Ibrahim el C., Guedj E., Blin O., Weinberger D.R., Fakra E. Dissociating bottom-up and top-down mechanisms in the cortico-limbic system during emotion processing. Cereb. Cortex 2016, 26:144-155.
26. Cooper E. Nicotinic acetylcholine receptors on vagal afferent neurons. Ann. N. Y. Acad. Sci. 2001, 940:110-118.
27. Coryell M.W., Ziemann A.E., Westmoreland P.J., Haenfler J.M., Kurjakovic Z., Zha X.M., Price M., Schnizler M.K., Wemmie J.A. Targeting ASIC1a reduces innate fear and alters neuronal activity in the fear circuit. Biol. Psychiatry 2007, 62:1140-1148.
28. Coryell M.W., Wunsch A.M., Haenfler J.M., Allen J.E., Schnizler M., Ziemann A.E., Cook M.N., Dunning J.P., Price M.P., Rainier J.D., Liu Z., Light A.R., Langbehn D.R., Wemmie J.A. Acid-sensing ion channel-1a in the amygdala, a novel therapeutic target in depression-related behavior. J. Neurosci. 2009, 29:5381-5388.
29. Cristino L., de Petrocellis L., Pryce G., Baker D., Guglielmotti V., Di Marzo V. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 2006, 139:1405-1415.
30. Csala I., Egervari L., Dome P., Faludi G., Dome B., Lazary J. The possible role of maternal bonding style and CHRNB2 gene polymorphisms in nicotine dependence and related depressive phenotype. Prog. Neuropsychopharmacol. Biol. Psychiatry 2015, 59:84-90.
31. Daigle N.D., Carpentier G.A., Frenette-Cotton R., Simard M.G., Lefoll M.H., Noel M., Caron L., Noel J., Isenring P. Molecular characterization of a human cation-Cl- cotransporter (SLC12A8A, CCC9A) that promotes polyamine and amino acid transport. J. Cell. Physiol. 2009, 220:680-689.
32. Danzer S.C. Depression, stress, epilepsy and adult neurogenesis. Exp. Neurol. 2012, 233:22-32.
33. Dao D.T., Mahon P.B., Cai X., Kovacsics C.E., Blackwell R.A., Arad M., Shi J., Zandi P.P., O'Donnell P., Knowles J.A., Weissman M.M., Coryell W., Scheftner W.A., Lawson W.B., Levinson D.F., Thompson S.M., Potash J.B., Gould T.D. Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans. Biol. Psychiatry 2012, 68:801-810.
34. Davidson R.J., Pizzagalli D., Nitschke J.B., Putnam K. Depression: perspectives from affective neuroscience. Annu. Rev. Psychol. 2002, 53:545-574.
35. Dierker L., Rose J., Selya A., Piasecki T.M., Hedeker D., Mermelstein R. Depression and nicotine dependence from adolescence to young adulthood. Addict. Behav. 2015, 41:124-128.
36. Drevets W.C., Furey M.L. Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial. Biol. Psychiatry 2010, 67:432-438.
37. Du J., Reznikov L.R., Price M.P., Zha X.M., Lu Y., Moninger T.O., Wemmie J.A., Welsh M.J. Protons are a neurotransmitter that regulates synaptic plasticity in the lateral amygdala. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:8961-8966.
38. Dube C.M., Molet J., Singh-Taylor A., Ivy A., Maras P.M., Baram T.Z. Hyper-excitability and epilepsy generated by chronic early-life stress. Neurobiol. Stress 2015, 2:10-19.
39. Duman R.S., Li N., Liu R.J., Duric V., Aghajanian G. Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 2012, 62:35-41.
40. Duric V., Banasr M., Licznerski P., Schmidt H.D., Stockmeier C.A., Simen A.A., Newton S.S., Duman R.S. A negative regulator of MAP kinase causes depressive behavior. Nat. Med. 2010, 16:1328-1332.
41. Dwivedi Y., Rizavi H.S., Roberts R.C., Conley R.C., Tamminga C.A., Pandey G.N. Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J. Neurochem. 2001, 77:916-928.
42. Ellis J.R., Ellis K.A., Bartholomeusz C.F., Harrison B.J., Wesnes K.A., Erskine F.F., Vitetta L., Nathan P.J. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans. Int. J. Neuropsychopharmacol. 2006, 9:175-189.
43. Fabbri C., Serretti A. Genetics of long-term treatment outcome in bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2016, 65:17-24.
44. Fage D., Voltz C., Scatton B., Carter C. Selective release of spermine and spermidine from the rat striatum by N-methyl-d-aspartate receptor activation in vivo. J. Neurochem. 1992, 58:2170-2175.
45. Fage D., Voltz C., Carter C. Ouabain releases striatal polyamines in vivo independently of N-methyl-d-aspartate receptor activation. J. Neurochem. 1993, 61:261-265.
46. Fales C.L., Barch D.M., Rundle M.M., Mintun M.A., Snyder A.Z., Cohen J.D., Mathews J., Sheline Y.I. Altered emotional interference processing in affective and cognitive-control brain circuitry in major depression. Biol. Psychiatry 2008, 63:377-384.
47. Fiori L.M., Mechawar N., Turecki G. Identification and characterization of spermidine/spermine N1-acetyltransferase promoter variants in suicide completers. Biol. Psychiatry 2009, 66:460-467.
48. Fiori L.M., Bureau A., Labbe A., Croteau J., Noel S., Merette C., Turecki G. Global gene expression profiling of the polyamine system in suicide completers. Int. J. Neuropsychopharmacol. 2011, 14:595-605.
49. + channels. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:18994-18999.
50. Forsgren L., Nystrom L. An incident case-referent study of epileptic seizures in adults. Epilepsy Res. 1990, 6:66-81.
51. Furey M.L., Drevets W.C. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Arch. Gen. Psychiatry 2006, 63:1121-1129.
52. Gallagher M.J., Huang H., Grant E.R., Lynch D.R. The NR2B-specific interactions of polyamines and protons with the N-methyl-d-aspartate receptor. J. Biol. Chem. 1997, 272:24971-24979.
53. Gerzanich V., Anand R., Lindstrom J. Homomers of alpha 8 and alpha 7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties. Mol. Pharmacol. 1994, 45:212-220.
54. Gilad G.M., Gilad V.H. Brain polyamine stress response: recurrence after repetitive stressor and inhibition by lithium. J. Neurochem. 1996, 67:1992-1996.
55. Gilad G.M., Gilad V.H. Overview of the brain polyamine-stress-response: regulation, development, and modulation by lithium and role in cell survival. Cell. Mol. Neurobiol. 2003, 23:637-649.
56. Gilad G.M., Gilad V.H., Wyatt R.J. Polyamines modulate the binding of GABAA-benzodiazepine receptor ligands in membranes from the rat forebrain. Neuropharmacology 1992, 31:895-898.
57. Gilad G.M., Gilad V.H., Wyatt R.J., Casero R.A. Chronic lithium treatment prevents the dexamethasone-induced increase of brain polyamine metabolizing enzymes. Life Sci. 1992, 50:PL149-154.
58. Gray A.L., Hyde T.M., Deep-Soboslay A., Kleinman J.E., Sodhi M.S. Sex differences in glutamate receptor gene expression in major depression and suicide. Mol. Psychiatry 2015, 20:1057-1068.
59. Gribkoff V.K., Starrett J.E., Dworetzky S.I. Maxi-K potassium channels: form, function, and modulation of a class of endogenous regulators of intracellular calcium. Neuroscientist 2001, 7:166-177.
60. Gross J.A., Fiori L.M., Labonte B., Lopez J.P., Turecki G. Effects of promoter methylation on increased expression of polyamine biosynthetic genes in suicide. J. Psychiatry Res. 2013, 47:513-519.
61. Guipponi M., Deutsch S., Kohler K., Perroud N., Le Gal F., Vessaz M., Laforge T., Petit B., Jollant F., Guillaume S., Baud P., Courtet P., La Harpe R., Malafosse A. Genetic and epigenetic analysis of SSAT gene dysregulation in suicidal behavior. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B:799-807.
62. Guipponi M., Deutsch S., Kohler K., Perroud N., Le G.F., Vessaz M., Laforge T., Petit B., Jollant F., Guillaume S., Baud P., Courtet P., La H.R., Malafosse A. Genetic and epigenetic analysis of SSAT gene dysregulation in suicidal behavior. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B:799-807.
63. 2+-activated potassium channels in the lateral amygdala. J. Physiol. 2012, 590:875-886.
64. Haber M.T., Fukui T., Lebowitz M.S., Lowenstein J.M. Activation of phosphoinositide-specific phospholipase C delta from rat liver by polyamines and basic proteins. Arch. Biochem. Biophys. 1991, 288:243-249.
65. Haghighi A.P., Cooper E. Neuronal nicotinic acetylcholine receptors are blocked by intracellular spermine in a voltage-dependent manner. J. Neurosci. 1998, 18:4050-4062.
66. Haghighi A.P., Cooper E. A molecular link between inward rectification and calcium permeability of neuronal nicotinic acetylcholine alpha3beta4 and alpha4beta2 receptors. J. Neurosci. 2000, 20:529-541.
67. Hammen C. Stress and depression. Annu. Rev. Clin. Psychol. 2005, 1:293-319.
68. Hankin B.L., Mermelstein R., Roesch L. Sex differences in adolescent depression: stress exposure and reactivity models. Child Dev. 2007, 78:279-295.
69. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., Egan M.F., Weinberger D.R. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002, 297:400-403.
70. Harman R.J., Shaw G.G. The spontaneous and evoked release of spermine from rat brain in vitro. Br. J. Pharmacol. 1981, 73:165-174.
71. Hasler G., Northoff G. Discovering imaging endophenotypes for major depression. Mol. Psychiatry 2011, 16:604-619.
72. Hawrylycz M.J., Lein E.S., Guillozet-Bongaarts A.L., Shen E.H., Ng L., Miller J.A., van de Lagemaat L.N., Smith K.A., Ebbert A., Riley Z.L., Abajian C., Beckmann C.F., Bernard A., Bertagnolli D., Boe A.F., Cartagena P.M., Chakravarty M.M., Chapin M., Chong J., Dalley R.A., Daly B.D., Dang C., Datta S., Dee N., Dolbeare T.A., Faber V., Feng D., Fowler D.R., Goldy J., Gregor B.W., Haradon Z., Haynor D.R., Hohmann J.G., Horvath S., Howard R.E., Jeromin A., Jochim J.M., Kinnunen M., Lau C., Lazarz E.T., Lee C., Lemon T.A., Li L., Li Y., Morris J.A., Overly C.C., Parker P.D., Parry S.E., Reding M., Royall J.J., Schulkin J., Sequeira P.A., Slaughterbeck C.R., Smith S.C., Sodt A.J., Sunkin S.M., Swanson B.E., Vawter M.P., Williams D., Wohnoutka P., Zielke H.R., Geschwind D.H., Hof P.R., Smith S.M., Koch C., Grant S.G., Jones A.R. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 2012, 489:391-399.
73. Herman M.D., Reuveny E., Narahashi T. The effect of polyamines on voltage-activated calcium channels in mouse neuroblastoma cells. J. Physiol. 1993, 462:645-660.
74. Herz J., Chen Y. Reelin, lipoprotein receptors and synaptic plasticity. Nat. Rev. Neurosci. 2006, 7:850-859.
75. Hesdorffer D.C., Hauser W.A., Annegers J.F., Cascino G. Major depression is a risk factor for seizures in older adults. Ann. Neurol. 2000, 47:246-249.
76. Heurteaux C., Lucas G., Guy N., El Yacoubi M., Thummler S., Peng X.D., Noble F., Blondeau N., Widmann C., Borsotto M., Gobbi G., Vaugeois J.M., Debonnel G., Lazdunski M. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat. Neurosci. 2006, 9:1134-1141.
77. Hille B. Ion Channels of Excitable Membranes 2001, Sinauer Associates Inc. third ed.
78. Hofer A.M., Brown E.M. Extracellular calcium sensing and signalling. Nat. Rev. Mol. Cell Biol. 2003, 4:530-538.
79. Hume R.I., Dingledine R., Heinemann S.F. Identification of a site in glutamate receptor subunits that controls calcium permeability. Science 1991, 253:1028-1031.
80. Igarashi K., Kashiwagi K. Modulation of cellular function by polyamines. Int. J. Biochem. Cell Biol. 2010, 42:39-51.
81. Isaev D., Ivanchick G., Khmyz V., Isaeva E., Savrasova A., Krishtal O., Holmes G.L., Maximyuk O. Surface charge impact in low-magnesium model of seizure in rat hippocampus. J. Neurophysiol. 2012, 107:417-423.
82. Ishihara K., Hiraoka M., Ochi R. The tetravalent organic cation spermine causes the gating of the IRK1 channel expressed in murine fibroblast cells. J. Physiol. 1996, 491(Pt 2):367-381.
83. Janowsky D.S., el-Yousef M.K., Davis J.M., Sekerke H.J. A cholinergic-adrenergic hypothesis of mania and depression. Lancet 1972, 2:632-635.
84. Joels M., Karst H. Corticosteroid effects on calcium signaling in limbic neurons. Cell Calcium 2011, 51:277-283.
85. Johnson T.D. Modulation of channel function by polyamines. Trends Pharmacol. Sci. 1996, 17:22-27.
86. Kanner A.M. Depression and epilepsy: a bidirectional relation?. Epilepsia 2011, 52(Suppl 1):21-27.
87. Kendler K.S., Karkowski L.M., Prescott C.A. Stressful life events and major depression: risk period, long-term contextual threat, and diagnostic specificity. J. Nerv. Ment. Dis. 1998, 186:661-669.
88. Kerschbaum H.H., Kozak J.A., Cahalan M.D. Polyvalent cations as permeant probes of MIC and TRPM7 pores. Biophys. J. 2003, 84:2293-2305.
89. Klempan T.A., Rujescu D., Merette C., Himmelman C., Sequeira A., Canetti L., Fiori L.M., Schneider B., Bureau A., Turecki G. Profiling brain expression of the spermidine/spermine N1-acetyltransferase 1 (SAT1) gene in suicide. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B:934-943.
90. Klempan T.A., Sequeira A., Canetti L., Lalovic A., Ernst C., Ffrench-Mullen J., Turecki G. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol. Psychiatry 2009, 14:175-189.
91. Koenig H., Goldstone A.D., Trout J.J., Lu C.Y. Polyamines mediate uncontrolled calcium entry and cell damage in rat heart in the calcium paradox. J. Clin. Invest. 1987, 80:1322-1331.
92. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
93. Kucheryavykh Y.V., Pearson W.L., Kurata H.T., Eaton M.J., Skatchkov S.N., Nichols C.G. Polyamine permeation and rectification of Kir4.1 channels. Channels (Austin) 2007, 1:172-178.
94. Labonte B., Suderman M., Maussion G., Lopez J.P., Navarro-Sanchez L., Yerko V., Mechawar N., Szyf M., Meaney M.J., Turecki G. Genome-wide methylation changes in the brains of suicide completers. Am. J. Psychiatry 2013, 170:511-520.
95. Laje G., Paddock S., Manji H., Rush A.J., Wilson A.F., Charney D., McMahon F.J. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am. J. Psychiatry 2007, 164:1530-1538.
96. Langdon R.C., Fleckman P., McGuire J. Calcium stimulates ornithine decarboxylase activity in cultured mammalian epithelial cells. J. Cell. Physiol. 1984, 118:39-44.
97. 2+ channels in bipolar cells by divalent cations and polyamines. Adv. Exp. Med. Biol. 2002, 514:275-289.
98. Li N., Lee B., Liu R.J., Banasr M., Dwyer J.M., Iwata M., Li X.Y., Aghajanian G., Duman R.S. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329:959-964.
99. +-current density is correlated with soma size in rat vestibular-afferent neurons in culture. J. Neurophysiol. 2005, 94:3751-3761.
100. Liou Y.J., Chen T.J., Tsai S.J., Yu Y.W., Cheng C.Y., Hong C.J. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment. Pharmacogenet. Genom. 2009, 19:735-741.
101. Liu Y., Blackwood D.H., Caesar S., de Geus E.J., Farmer A., Ferreira M.A., Ferrier I.N., Fraser C., Gordon-Smith K., Green E.K., Grozeva D., Gurling H.M., Hamshere M.L., Heutink P., Holmans P.A., Hoogendijk W.J., Hottenga J.J., Jones L., Jones I.R., Kirov G., Lin D., McGuffin P., Moskvina V., Nolen W.A., Perlis R.H., Posthuma D., Scolnick E.M., Smit A.B., Smit J.H., Smoller J.W., St Clair D., van Dyck R., Verhage M., Willemsen G., Young A.H., Zandbelt T., Boomsma D.I., Craddock N., O'Donovan M.C., Owen M.J., Penninx B.W., Purcell S., Sklar P., Sullivan P.F. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol. Psychiatry 2011, 16:2-4.
102. Logothetis N.K. The underpinnings of the BOLD functional magnetic resonance imaging signal. J. Neurosci. 2003, 23:3963-3971.
103. Lopatin A.N., Makhina E.N., Nichols C.G. Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification. Nature 1994, 372:366-369.
104. Lu B., Zhang Q., Wang H., Wang Y., Nakayama M., Ren D. Extracellular calcium controls background current and neuronal excitability via an UNC79-UNC80-NALCN cation channel complex. Neuron 2010, 68:488-499.
105. Maeng S., Zarate C.A., Du J., Schloesser R.J., McCammon J., Chen G., Manji H.K. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol. Psychiatry 2008, 63:349-352.
106. Marsch R., Foeller E., Rammes G., Bunck M., Kossl M., Holsboer F., Zieglgansberger W., Landgraf R., Lutz B., Wotjak C.T. Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. J. Neurosci. 2007, 27:832-839.
107. Masuko T., Kusama-Eguchi K., Sakata K., Kusama T., Chaki S., Okuyama S., Williams K., Kashiwagi K., Igarashi K. Polyamine transport, accumulation, and release in brain. J. Neurochem. 2003, 84:610-617.
108. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., Silva J.A., Tekell J.L., Martin C.C., Lancaster J.L., Fox P.T. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry 1999, 156:675-682.
109. Meadows H.J., Benham C.D., Cairns W., Gloger I., Jennings C., Medhurst A.D., Murdock P., Chapman C.G. Cloning, localisation and functional expression of the human orthologue of the TREK-1 potassium channel. Pflug. Arch. 2000, 439:714-722.
110. Miller O.H., Moran J.T., Hall B.J. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: direct inhibition and disinhibition. Neuropharmacology 2016, 100:17-26.
111. Mineur Y.S., Obayemi A., Wigestrand M.B., Fote G.M., Calarco C.A., Li A.M., Picciotto M.R. Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:3573-3578.
112. Mineur Y.S., Fote G.M., Blakeman S., Cahuzac E.L., Newbold S.A., Picciotto M.R. Multiple nicotinic acetylcholine receptor subtypes in the mouse amygdala regulate affective behaviors and response to social stress. Neuropsychopharmacology 2016, 41:1579-1587.
113. Moldoveanu T., Hosfield C.M., Lim D., Elce J.S., Jia Z., Davies P.L. A Ca(2+) switch aligns the active site of calpain. Cell 2002, 108:649-660.
114. Mony L., Kew J.N., Gunthorpe M.J., Paoletti P. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential. Br. J. Pharmacol. 2009, 157:1301-1317.
115. Mott D.D., Washburn M.S., Zhang S., Dingledine R.J. Subunit-dependent modulation of kainate receptors by extracellular protons and polyamines. J. Neurosci. 2003, 23:1179-1188.
116. Murrough J.W., Iosifescu D.V., Chang L.C., Al Jurdi R.K., Green C.E., Perez A.M., Iqbal S., Pillemer S., Foulkes A., Shah A., Charney D.S., Mathew S.J. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am. J. Psychiatry 2013, 170:1134-1142.
117. + channel TASK-3 and on the outward current in thalamic neurons. J. Physiol. 2006, 572:639-657.
118. Nagy C., Suderman M., Yang J., Szyf M., Mechawar N., Ernst C., Turecki G. Astrocytic abnormalities and global DNA methylation patterns in depression and suicide. Mol. Psychiatry 2014, 20:320-328.
119. 2+-activated cation channel TRPM4b. Pflug. Arch. 2004, 448:70-75.
120. Otani S., Matsui I., Kuramoto A., Morisawa S. Induction of ornithine decarboxylase in guinea-pig lymphocytes: synergistic effect of diacylglycerol and calcium. Eur. J. Biochem. 1985, 147:27-31.
121. Pajunen A.E., Hietala O.A., Virransalo E.L., Piha R.S. Ornithine decarboxylase and adenosylmethionine decarboxylase in mouse brain-effect of electrical stimulation. J. Neurochem. 1978, 30:281-283.
122. Pantazatos S.P., Andrews S.J., Dunning-Broadbent J., Pang J., Huang Y.Y., Arango V., Nagy P.L., John M.J. Isoform-level brain expression profiling of the spermidine/spermine N1-acetyltransferase1 (SAT1) gene in major depression and suicide. Neurobiol. Dis 2015, 79:123-134.
123. Pegg A.E. Mammalian polyamine metabolism and function. IUBMB Life 2009, 61:880-894.
124. Pellegrini-Giampietro D.E. An activity-dependent spermine-mediated mechanism that modulates glutamate transmission. Trends Neurosci. 2003, 26:9-11.
125. Pernet V., Bourgeois P., Di Polo A. A role for polyamines in retinal ganglion cell excitotoxic death. J. Neurochem. 2007, 103:1481-1490.
126. Pizzagalli D.A., Peccoralo L.A., Davidson R.J., Cohen J.D. Resting anterior cingulate activity and abnormal responses to errors in subjects with elevated depressive symptoms: a 128-channel EEG study. Hum. Brain Mapp. 2006, 27:185-201.
127. Preskorn S.H., Baker B., Kolluri S., Menniti F.S., Krams M., Landen J.W. An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-d-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder. J. Clin. Psychopharmacol. 2008, 28:631-637.
128. Quinn S.J., Ye C.P., Diaz R., Kifor O., Bai M., Vassilev P., Brown E. The Ca2+-sensing receptor: a target for polyamines. Am. J. Physiol. 1997, 273:C1315-1323.
129. Refojo D., Echenique C., Muller M.B., Reul J.M., Deussing J.M., Wurst W., Sillaber I., Paez-Pereda M., Holsboer F., Arzt E. Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:6183-6188.
130. Reinstatler L., Youssef N.A. Ketamine as a potential treatment for suicidal ideation: a systematic review of the literature. Drugs R. D. 2015, 15:37-43.
131. Reis D.J., Regunathan S. Is agmatine a novel neurotransmitter in brain?. Trends Pharmacol. Sci. 2000, 21:187-193.
132. Ritov G., Ardi Z., Richter-Levin G. Differential activation of amygdala, dorsal and ventral hippocampus following an exposure to a reminder of underwater trauma. Front. Behav. Neurosci. 2014, 8:18.
133. Rock D.M., Macdonald R.L. Polyamine regulation of N-methyl-D-aspartate receptor channels. Annu. Rev. Pharmacol. Toxicol. 1995, 35:463-482.
134. Rosenkranz J.A., Venheim E.R., Padival M. Chronic stress causes amygdala hyperexcitability in rodents. Biol. Psychiatry 2010, 67:1128-1136.
135. Sastre M., Regunathan S., Galea E., Reis D.J. Agmatinase activity in rat brain: a metabolic pathway for the degradation of agmatine. J. Neurochem. 1996, 67:1761-1765.
136. Schosser A., Butler A.W., Uher R., Ng M.Y., Cohen-Woods S., Craddock N., Owen M.J., Korszun A., Gill M., Rice J., Hauser J., Henigsberg N., Maier W., Mors O., Placentino A., Rietschel M., Souery D., Preisig M., Craig I.W., Farmer A.E., Lewis C.M., McGuffin P. Genome-wide association study of co-occurring anxiety in major depression. World J. Biol. Psychiatry 2013, 14:611-621.
137. Scriver C.R. Human genetics: lessons from Quebec populations. Annu. Rev. Genom. Hum. Genet. 2001, 2:69-101.
138. Sequeira A., Gwadry F.G., Ffrench-Mullen J.M., Canetti L., Gingras Y., Casero R.A., Rouleau G., Benkelfat C., Turecki G. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch. Gen. Psychiatry 2006, 63:35-48.
139. Sequeira A., Klempan T., Canetti L., Ffrench-Mullen J., Benkelfat C., Rouleau G.A., Turecki G. Patterns of gene expression in the limbic system of suicides with and without major depression. Mol. Psychiatry 2007, 12:640-655.
140. Sequeira A., Mamdani F., Ernst C., Vawter M.P., Bunney W.E., Lebel V., Rehal S., Klempan T., Gratton A., Benkelfat C., Rouleau G.A., Mechawar N., Turecki G. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One 2009, 4:e6585.
141. Sheline Y.I., Barch D.M., Donnelly J.M., Ollinger J.M., Snyder A.Z., Mintun M.A. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol. Psychiatry 2001, 50:651-658.
142. Shi J., Potash J.B., Knowles J.A., Weissman M.M., Coryell W., Scheftner W.A., Lawson W.B., DePaulo J.R., Gejman P.V., Sanders A.R., Johnson J.K., Adams P., Chaudhury S., Jancic D., Evgrafov O., Zvinyatskovskiy A., Ertman N., Gladis M., Neimanas K., Goodell M., Hale N., Ney N., Verma R., Mirel D., Holmans P., Levinson D.F. Genome-wide association study of recurrent early-onset major depressive disorder. Mol. Psychiatry 2011, 16:193-201.
143. Shopsin B. The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study. Acta Neuropsychiatry 2013, 25:113-118.
144. Shumake J., Gonzalez-Lima F. Brain systems underlying susceptibility to helplessness and depression. Behav. Cogn. Neurosci. Rev. 2003, 2:198-221.
145. Siegle G.J., Steinhauer S.R., Thase M.E., Stenger V.A., Carter C.S. Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol. Psychiatry 2002, 51:693-707.
146. Sokolowski M., Ben-Efraim Y.J., Wasserman J., Wasserman D. Glutamatergic GRIN2B and polyaminergic ODC1 genes in suicide attempts: associations and gene-environment interactions with childhood/adolescent physical assault. Mol. Psychiatry 2013, 18:985-992.
147. Squassina A., Manchia M., Chillotti C., Deiana V., Congiu D., Paribello F., Roncada P., Soggiu A., Piras C., Urbani A., Robertson G.S., Keddy P., Turecki G., Rouleau G.A., Alda M., Del Zompo M. Differential effect of lithium on spermidine/spermine N1-acetyltransferase expression in suicidal behaviour. Int. J. Neuropsychopharmacol. 2013, 16:2209-2218.
148. + channels. J. Gen. Physiol. 2007, 130:241-256.
149. Teixeira C.M., Martin E.D., Sahun I., Masachs N., Pujadas L., Corvelo A., Bosch C., Rossi D., Martinez A., Maldonado R., Dierssen M., Soriano E. Overexpression of Reelin prevents the manifestation of behavioral phenotypes related to schizophrenia and bipolar disorder. Neuropsychopharmacology 2011, 36:2395-2405.
150. Tennant C. Life events, stress and depression: a review of recent findings. Aust. N. Z. J. Psychiatry 2002, 36:173-182.
151. Tovilla-Zárate C.A., López-Narváez M.L., González-Castro T.B., Juárez-Rojop I., Pool-García S., Genis A., Ble-Castillo J., Fresán A., Nicolini H. Association between the SAT-1 gene and suicidal behavior in mexican population. J. Psychiatry 2015, S1:005.
152. Traynelis S.F., Hartley M., Heinemann S.F. Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science 1995, 268:873-876.
153. Traynelis S.F., Wollmuth L.P., McBain C.J., Menniti F.S., Vance K.M., Ogden K.K., Hansen K.B., Yuan H., Myers S.J., Dingledine R. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol. Rev. 2010, 62:405-496.
154. Trentani A., Kuipers S.D., Ter Horst G.J., Den Boer J.A. Selective chronic stress-induced in vivo ERK1/2 hyperphosphorylation in medial prefrontocortical dendrites: implications for stress-related cortical pathology?. Eur. J. Neurosci. 2002, 15:1681-1691.
155. Turecki G. The molecular bases of the suicidal brain. Nat. Rev. Neurosci. 2014, 15:802-816.
156. 2+-activated cation channels TRPM4 and TRPM5 from mice. Cell Calcium 2005, 37:267-278.
157. Van Der Stelt M., Di Marzo V. Endovanilloids: putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur. J. Biochem. 2004, 271:1827-1834.
158. Van Leeuwen J.P., Bos M.P., Herrmann-Erlee M.P. Parathyroid hormone-induced ornithine decarboxylase activity in fetal rat osteoblasts. J. Bone Miner. Res. 1989, 4:485-492.
159. 2+ is a voltage-dependent pore blocker of HCN channels. Am. J. Physiol. Cell Physiol. 2008, 295:C557-565.
160. Verdoorn T.A., Burnashev N., Monyer H., Seeburg P.H., Sakmann B. Structural determinants of ion flow through recombinant glutamate receptor channels. Science 1991, 252:1715-1718.
161. WHO, 2011. World report on disability.
162. Wasserman D., Geijer T., Rozanov V., Wasserman J. Suicide attempt and basic mechanisms in neural conduction: relationships to the SCN8A and VAMP4 genes. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 133B:116-119.
163. + channels in pituitary tumor cells (GH3). J. Membr. Biol. 1994, 140:133-142.
164. Weiger T.M., Langer T., Hermann A. External action of di- and polyamines on maxi calcium-activated potassium channels: an electrophysiological and molecular modeling study. Biophys. J. 1998, 74:722-730.
165. Wemmie J.A., Askwith C.C., Lamani E., Cassell M.D., Freeman J.H., Welsh M.J. Acid-sensing ion channel 1 is localized in brain regions with high synaptic density and contributes to fear conditioning. J. Neurosci. 2003, 23:5496-5502.
166. Wemmie J.A., Coryell M.W., Askwith C.C., Lamani E., Leonard A.S., Sigmund C.D., Welsh M.J. Overexpression of acid-sensing ion channel 1a in transgenic mice increases acquired fear-related behavior. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3621-3626.
167. Williams K., Zappia A.M., Pritchett D.B., Shen Y.M., Molinoff P.B. Sensitivity of the N-methyl-d-aspartate receptor to polyamines is controlled by NR2 subunits. Mol. Pharmacol. 1994, 45:803-809.
168. Williams K., Kashiwagi K., Fukuchi J., Igarashi K. An acidic amino acid in the N-methyl-d-aspartate receptor that is important for spermine stimulation. Mol. Pharmacol. 1995, 48:1087-1098.
169. Wong T.P., Howland J.G., Robillard J.M., Ge Y., Yu W., Titterness A.K., Brebner K., Liu L., Weinberg J., Christie B.R., Phillips A.G., Wang Y.T. Hippocampal long-term depression mediates acute stress-induced spatial memory retrieval impairment. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:11471-11476.
170. + channel. Neuron 1995, 14:1047-1054.
171. Zhang L., Zheng X., Paupard M.C., Wang A.P., Santchi L., Friedman L.K., Zukin R.S., Bennett M.V. Spermine potentiation of recombinant N-methyl-d-aspartate receptors is affected by subunit composition. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:10883-10887.
172. Zhang C., Li Z., Wu Z., Chen J., Wang Z., Peng D., Hong W., Yuan C., Yu S., Xu Y., Xu L., Xiao Z., Fang Y. A study of N-methyl-d-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression. Psychopharmacology (Berl.) 2014, 231:685-693.
173. Zhang H., Xue G., Zhang W., Wang L., Li H., Zhang L., Lu F., Bai S., Lin Y., Lou Y., Xu C., Zhao Y. Akt and Erk1/2 activate the ornithine decarboxylase/polyamine system in cardioprotective ischemic preconditioning in rats: the role of mitochondrial permeability transition pores. Mol. Cell. Biochem. 2014, 390:133-142.
174. Zomkowski A.D., Hammes L., Lin J., Calixto J.B., Santos A.R., Rodrigues A.L. Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport 2002, 13:387-391.
175. Zschenderlein C., Gebhardt C., von Bohlen Und Halbach O., Kulisch C., Albrecht D. Capsaicin-induced changes in LTP in the lateral amygdala are mediated by TRPV1. PLoS One 2011, 6:e16116.